<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>FDA现在正在审查第三种由强生公司生产的COVID疫苗 FDA now reviewing a third COVID vaccine, this one made by Johnson & Johnson</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script>
<script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">FDA now reviewing a third COVID vaccine, this one made by Johnson & Johnson<br/>FDA现在正在审查第三种由强生公司生产的COVID疫苗 </h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2021-02-06 21:01:23</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2021/2/0b5ee5fb5090ef525342afdec2a514a6.jpg"><img src="http://img2.diglog.com/img/2021/2/0b5ee5fb5090ef525342afdec2a514a6.jpg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>Johnson &amp; Johnson on Thursday  announced it has applied to the US Food and Drug Administration for an Emergency Use Authorization for its one-shot COVID-19 vaccine.</p><p>强生公司约翰逊星期四宣布已向美国食品和药物管理局申请了一次注射的COVID-19疫苗的紧急使用授权。</p><p> If the EUA is granted, the vaccine will be the third authorized for use in the US against the pandemic coronavirus, likely boosting the vaccine supply in the coming months and helping to hasten immunization country-wide.</p><p> 如果获得EUA批准，该疫苗将是美国第三种针对大流行性冠状病毒使用的授权疫苗，这有可能在未来几个月内增加疫苗供应，并有助于在全国范围内加速免疫。</p><p> J&amp;J’s application to the FDA comes just a week after the company revealed  top-line results of its Phase III clinical trial, which found the vaccine to be 66 percent effective overall at preventing moderate and severe COVID-19. J&amp;J’s vaccine—made by its vaccine developer Janssen Pharmaceuticals—was 85 percent effective at preventing severe disease. In the trial, severe disease was defined as testing positive for the virus as well as having signs consistent with severe systemic illness, respiratory failure, shock, or organ failure, or being admitted to an intensive care unit, or dying. The company reported that no one who received the vaccine was hospitalized or died during the trial.</p><p> 强生向FDA申请是在该公司公布其III期临床试验的主要结果后一周，该研究发现该疫苗在预防中度和重度COVID-19方面总体上有66％的有效率。强生公司的疫苗开发商詹森制药（Janssen Pharmaceuticals）生产的疫苗对预防严重疾病的有效率为85％。在该试验中，严重疾病的定义是对病毒的检测呈阳性，并且具有与严重的全身性疾病，呼吸衰竭，休克或器官衰竭，或被送往重症监护病房或正在死亡的体征一致的迹象。该公司报告说，没有人在试验期间住院或死亡。</p><p> Notably, the vaccine’s efficacy differed based on location—the Phase III trial enrolled people in various sites in Argentina, Brazil, Chile, Colombia, Mexico, Peru, South Africa, and the United States. The vaccine’s efficacy against preventing moderate and severe COVID-19 was 72 percent in the United States, 66 percent in Latin America, and 57 percent in South Africa 28 days after vaccination. The finding suggests that virus variants widely circulating in South Africa and Latin America may partly reduce efficacy.</p><p> 值得注意的是，疫苗的功效因位置而异-这项III期试验招募了阿根廷，巴西，智利，哥伦比亚，墨西哥，秘鲁，南非和美国不同地点的人们。接种28天后，该疫苗在预防中度和重度COVID-19方面的功效在美国为72％，在拉丁美洲为66％，在南非为57％。该发现表明，在南非和拉丁美洲广泛传播的病毒变体可能会部分降低功效。</p><p>     The FDA will now pore over the full data from J&amp;J’s trial, and an advisory committee for the agency will weigh in. The whole process is expected to take several weeks.</p><p>     FDA现在将仔细研究J＆amp; J试验的全部数据，并将对该机构的咨询委员会进行评估。整个过程预计将需要数周的时间。</p><p> Though the top-line efficacy for the vaccine appears relatively low, experts have been quick to champion the vaccine and its prospects of helping to end the pandemic. The previously authorized vaccines—mRNA-based vaccines from Moderna and a partnership between Pfizer and BioNTech—both showed efficacy of around 95 percent in Phase III trials. However, experts argue that J&amp;J&#39;s overall 66 percent efficacy will still go a long way to prevent disease and save lives. The 85 percent efficacy against severe disease and the lack of deaths and hospitalizations in the trial are also extremely positive signs for the vaccine’s utility.</p><p> 尽管该疫苗的最高疗效似乎相对较低，但专家们很快就拥护该疫苗及其有助于终结大流行病的前景。先前授权的疫苗-来自Moderna的基于mRNA的疫苗以及辉瑞与BioNTech之间的合作关系-均在III期试验中显示出约95％的功效。但是，专家们认为，强生的总功效为66％，在预防疾病和挽救生命方面还有很长的路要走。在试验中，针对严重疾病的85％的疗效以及没有死亡和住院的情况，对于疫苗的实用性也是极为积极的迹象。</p><p> Additionally, J&amp;J’s vaccine, which is an adenovirus-vectored vaccine, has notable logistical advantages. While both the authorized mRNA vaccines require two shots, J&amp;J’s vaccine only requires one, making administration much simpler. It also does not require ultra-cold storage, like the mRNA vaccines, simplifying distribution.</p><p> 此外，强生疫苗是一种腺病毒载体疫苗，具有明显的后勤优势。虽然两种授权的mRNA疫苗都需要注射两次，但强生的疫苗只需要注射一次即可，从而使给药更加简单。它还不需要像mRNA疫苗那样的超冷储存，从而简化了分布。 </p><p> &#34;Our goal all along has been to create a simple, effective solution for the largest number of people possible and to have maximum impact to help end the pandemic,” Alex Gorsky, J&amp;J&#39;s CEO, said in a statement. “We’re proud to have reached this critical milestone, and our commitment to address this global health crisis continues with urgency for everyone, everywhere.”</p><p>“我们的目标一直是为尽可能多的人创造一个简单，有效的解决方案，并发挥最大的影响力来终结这一流行病，”强生首席执行官Alex Gorsky在接受采访时说。 一份声明。 “我们为实现这一重要里程碑感到自豪，我们对解决全球性健康危机的承诺仍在紧迫，对任何地方的每个人都是如此。” </p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://arstechnica.com/science/2021/02/johnson-johnson-submits-covid-19-vaccine-to-fda/">https://arstechnica.com/science/2021/02/johnson-johnson-submits-covid-19-vaccine-to-fda/</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/reviewing/">#reviewing</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/疫苗/">#疫苗</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/分享/">#分享</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy; 2020 diglog.com </div></div></body></html>